Macquarie Group LTD Assembly Biosciences, Inc. Transaction History

Macquarie Group LTD

  • $85.1 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$1.46 - $2.45 $1,331 - $2,234
-912 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$4.33 - $6.63 $1,208 - $1,849
-279 Reduced 23.43%
912 $4,000
Q2 2020

Aug 11, 2020
BUY
$14.57 - $23.96 $17,352 - $28,536
1,191 New
1,191 $28,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email